Cormorant Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$78.3M Hold
2025
Q1
$45.1M Hold
2024
Q4
$62M Hold
2024
Q3
$66.5M Hold
2024
Q2
$72.4M Buy
2024
Q1
$142M Buy
2023
Q4
$140M Buy
2023
Q3
$25.6M Hold
2023
Q2
$27.8M Buy
2023
Q1
$662K Buy